CBS NewsImmunotherapy treatment shown safe in type 1 diabetes clinical trialCBS NewsA small clinical trial showed an immune system therapy was safe for people with type 1 diabetes, British researchers report. The immunotherapy also showed signs of help… Continue reading
Fred Hutch News ServiceDr. Carl June weaves together HIV and cancer research to advance cures for bothFred Hutch News ServiceUniversity of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental therapy for advan… Continue reading
|
UQ shares in $13m synthetic biology funding by CSIRO
UQ News Three of 11 nationwide recipients of Future Science Fellows – Dr Konstantinos Vavitsas, Dr Karen Weynberg, and Dr Jason Whitfield – will be hosted at UQ as part of the CSIRO Synthetic Biology Future Science Platform (SynBio FSP). Synthetic biology is a … |
|
UQ shares in $13m synthetic biology funding by CSIRO
UQ News Three of 11 nationwide recipients of Future Science Fellows – Dr Konstantinos Vavitsas, Dr Karen Weynberg, and Dr Jason Whitfield – will be hosted at UQ as part of the CSIRO Synthetic Biology Future Science Platform (SynBio FSP). Synthetic biology is a … |
The Guardian |
Peanut allergy cured in majority of children in immunotherapy trial
The Guardian A small clinical trial conducted at the Murdoch Children’s Research Institute has led to two-thirds of children treated with an experimental immunotherapy treatment being cured of their allergy. Importantly, this desensitisation to peanuts persisted … Australian Scientists Are On The Path To A Peanut Allergy CureGizmodo Australia Researchers unlock possible peanut allergy cureTen Eyewitness News Peanut allergy cure in sightThe West Australian |
West Hartford News |
Rare leukemia targeted by modifying patients’ immune cells
West Hartford News Turning the T cells into CAR–T cells helps by targeting the CD19 marker on the B cells. “CD19 happens to be a pretty good target for cancer technology because it’s only on B cells,” Gore said. “These new CAR–T cells latch onto the leukemia cells.”. |
OncLive |
Dr. Slovin on Approaches of Immunotherapy in Prostate Cancer
OncLive It’s important to recognize that immunotherapy encompasses more than checkpoint inhibitors, explains Slovin. There is a wide variety of other approaches that fall under the category of immunotherapy, such as antibodies, chimeric antigen receptor T … |